Normal view MARC view ISBD view

Competition between transcription factors HNF1 and HNF3, and alternative cell-specific activation by DBP and C/EBP contribute to the regulation of the liver-specific aldolase B promoter. [electronic resource]

By:

Gregori, C

Contributor(s):

Producer: 19930409Description: 897-903 p. digitalISSN:

0305-1048

Subject(s): Online resources:

Available from publisher's website

In: Nucleic acids research vol. 21

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

There are no comments on this title.

to post a comment.

Back to results

1 Results of early defibrillation program in Piacenza.
by Capucci, A
2 [Radioisotopic angiographic study of left ventricular function in hypertensive disease].
by Aschieri, D
3 [Life Project: the first European project of early defibrillation with first responders].
by Capucci, A
4 [How experimental models have influenced our physiopathological knowledge of a possible therapeutic approach to atrial fibrillation].
by Capucci, A
5 The role of EP-guided therapy in ventricular arrhythmias: beta-blockers, sotalol, and ICD's.
by Capucci, A
6 Clinical pharmacology of antiarrhythmic drugs.
by Capucci, A
7 [Epidemiology and therapy of atrial fibrillation].
by Capucci, A
8 Risk of complications of atrial fibrillation.
by Capucci, A
9 Myocardial ultrasonic tissue characterization in patients with different types of left ventricular hypertrophy: a videodensitometric approach.
by Zoni, A
10 Therapeutic options for malignant ventricular tachyarrhythmias: is the implantable cardioverter-defibrillator a primary alternative or merely complementary?
by Capucci, A
11 Safety of oral propafenone in the conversion of recent onset atrial fibrillation to sinus rhythm: a prospective parallel placebo-controlled multicentre study.
by Capucci, A
12 Effects of Class III drugs on atrial fibrillation.
by Capucci, A
13 The role of oral 1C antiarrhythmic drugs in terminating atrial fibrillation.
by Capucci, A
14 Clinical potential of emerging antiarrhythmic agents.
by Capucci, A
15 [Class-1C drugs for oral loading in the cardioversion of paroxysmal atrial fibrillation].
by Capucci, A
16 Oral amiodarone increases the efficacy of direct-current cardioversion in restoration of sinus rhythm in patients with chronic atrial fibrillation.
by Capucci, A
17 Comparison of therapy detection times between implantable cardioverter defibrillators with standard dual- and single-chamber pacing.
by Capucci, A
18 Multivariate analysis of the variables affecting left ventricular filling in normal subjects.
by Manca, C
19 Effect of aging on left ventricular filling in untreated hypertensive patients.
by Manca, C
20 Multidisciplinary and multisetting team management programme in heart failure patients affects hospitalisation and costing.
by Piepoli, M F